Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DNA hypomethylation restrains early antitumor immunity in prostate cancer [ChIP-seq and CUT&RUN]

ABSTRACT: DNA hypomethylation restrains early antitumor immunity in prostate cancer [ChIP-seq and CUT&RUN]

PROVIDER: PRJNA863247 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

DNA hypomethylation restrains early antitumor immunity in prostate cancer

Project description:DNA hypomethylation restrains early antitumor immunity in prostate cancer

| PRJNA860295 | ENA

DNA hypomethylation restrains early antitumor immunity in prostate cancer [Nanopore]

Project description:DNA hypomethylation restrains early antitumor immunity in prostate cancer [Nanopore]

| PRJNA864844 | ENA

DNA hypomethylation restrains early antitumor immunity in prostate cancer [RNAseq]

Project description:DNA hypomethylation restrains early antitumor immunity in prostate cancer [RNAseq]

| PRJNA860306 | ENA

DNA hypomethylation restrains early antitumor immunity in prostate cancer [DNA methylation]

Project description:DNA hypomethylation restrains early antitumor immunity in prostate cancer [DNA methylation]

| PRJNA860307 | ENA

DNA hypomethylation restrains early antitumor immunity in prostate cancer [ChIP-seq and CUT&RUN]

Project description:Cancer is characterized by hypomethylation-associated silencing of large chromatin domains, whose contribution to tumorigenesis is uncertain. Through high-resolution single cell DNA methylation sequencing in prostate cancer, we identify 40 core hypomethylation domains, consistently hypomethylated across tumor cells and arising at early stages of malignancy. Transcriptionally silenced genes within these domains are enriched for immune-related genes; nested among repressive domains are small loci with preserved methylation, encoding cell proliferation genes that escape silencing. Prominent among hypomethylation-silenced genes is a gene cluster harboring all five CD1 genes that present lipid antigens to NKT cells, and four IFI16-related interferon-inducible genes implicated in innate immunity. Re-expression of CD1 or IFI16 murine orthologs in immunocompetent mice abrogates prostate tumorigenesis, accompanied by activation of anti-tumor immunity. Thus, early epigenetic changes in cancer may shape tumorigenesis, targeting co-located genes within defined chromosomal loci. Hypomethylation domains are detectable in blood specimens enriched for circulating tumor cells.

2023-06-14 | GSE209967 | GEO

Bulk Cut&run and Cut&tag

Project description:Bulk Cut&run and Cut&tag

| PRJNA686390 | ENA

DNA hypomethylation restrains early antitumor immunity in prostate cancer [Nanopore]

2023-06-14 | GSE210260 | GEO

DNA hypomethylation restrains early antitumor immunity in prostate cancer [RNAseq]

2023-06-14 | GSE208448 | GEO

CUT&RUN HUDEP1 OE SOX6-Flag

Project description:SOX6 CUT&RUN on HUDEP1 over expressing SOX6-Flag. The experiment is done using and anti Flag Ab to assist the genome wide binding profile of SOX6 in HUDEP1 (Human Umbilical cord blood-Derived Erythroid Progenitor-1).

2023-04-07 | E-MTAB-12800 | biostudies-arrayexpress

DNA hypomethylation restrains early antitumor immunity in prostate cancer [DNA methylation]

2023-06-14 | GSE208447 | GEO